Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neutrophil cytosolic factor 1 (NCF1), also known as p47-phox, is a crucial cytosolic subunit of the NADPH oxidase (NOX) enzyme complex. NOX is essential for generating reactive oxygen species (ROS) in phagocytes, which are used to kill engulfed pathogens. NCF1 is activated by phosphorylation, leading to its translocation to the membrane and assembly with other NOX components to produce superoxide. NCF1 dysfunction is strongly associated with chronic granulomatous disease and increased risk for autoimmune disorders.
Not applicable (target is a protein subunit, not directly druggable itself, but involved in a druggable pathway)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neutrophil cytosolic factor 1 (p47-phox).